UBS Group’s Isleworth Healthcare Acquisition Corporation Warrant ISLEW Stock Holding History
Bought
Maintained
Sold
Other funds holding ISLEW
RCM
AC
MP
BFM
BL
EFI
PC
PAMP
RA
WC
UBS Group's ISLEW Position: Q2 2022 in Review
UBS Group sold out of Isleworth Healthcare Acquisition Corporation Warrant (ISLEW) in Q2 2022, closing a stake of 2,397 shares.
UBS Group first reported a position in ISLEW in Q2 2021 and held it in 4 quarters. The position peaked at $3K in Q2 2021. 46 funds tracked by Wall St. Rank hold ISLEW as of Q2 2022.
- UBS Group reported no remaining Isleworth Healthcare Acquisition Corporation Warrant position as of Q2 2022 after selling out during the quarter.
- UBS Group sold 2,397 Isleworth Healthcare Acquisition Corporation Warrant shares in Q2 2022.
- UBS Group first reported a position in Isleworth Healthcare Acquisition Corporation Warrant in Q2 2021 and held it in 4 quarters.
- UBS Group's Isleworth Healthcare Acquisition Corporation Warrant position peaked at $3K in Q2 2021.
- 46 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Warrant as of Q2 2022.
Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.